The effectiveness of the combination of rituximab and high-dose immunoglobulin in the immunomodulation of sensitized kidney transplant candidates. [electronic resource]
Producer: 20140311Description: E375-82 p. digitalISSN:- 1399-0012
- Adult
- Aged
- Antibodies, Monoclonal, Murine-Derived -- therapeutic use
- Desensitization, Immunologic
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Graft Rejection -- immunology
- HLA Antigens -- immunology
- Histocompatibility Testing
- Humans
- Immunoglobulins, Intravenous -- immunology
- Immunologic Factors -- therapeutic use
- Immunomodulation
- Isoantibodies -- blood
- Kidney Failure, Chronic -- immunology
- Kidney Transplantation
- Male
- Middle Aged
- Prognosis
- Rituximab
- Young Adult
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.